HomeNewsBusinessVFS Global customers preferring premium services after COVID-19: Pranav Sinha

VFS Global customers preferring premium services after COVID-19: Pranav Sinha

Indian travellers are preferring travel services that enable them to submit visa applications from the comfort, convenience and safety of their homes or offices, reducing human touch points and possible exposure to the coronavirus

April 14, 2022 / 21:12 IST
Story continues below Advertisement

VFS Global, the world’s largest visa outsourcing and technology specialist working with governments and diplomatic missions worldwide, is seeing more of its clients in India opt for premium services to speed up the processing of their travel documents in the aftermath of COVID-19.

Personalised services like visa at your doorstep, digital application submission, digital document check and eVisa caught on with customers since the pandemic reached Indian shores in March 2020, Pranav Sinha, head of  VFS Global in India and South Asia, told Moneycontrol.

Story continues below Advertisement

In India, VFS Global serves 50 clients through a network of 567 visa application centres spread over 17 locations.

The travel industry is expected to pay greater attention to digitalising business operations and more governments to integrate biometric enrolment in their visa application process, Sinha said. Edited excerpts: 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show